Thursday, February 25, 2021
Home News & Politics Delhi Medical Association Slams Doctors' Body For Criticising Health Minister

Delhi Medical Association Slams Doctors’ Body For Criticising Health Minister

Harsh Vardhan at the Coronil event.

New Delhi:

The Delhi Medical Association on Tuesday criticized the critical statement issued by the IMA on the launch of the Coronil tablet from Patanjali in the presence of Union Minister Harsh Vardhan.

The Indian Medical Association (IMA) on Monday expressed shock at the “blatant lie of WHO certification” for Patanjali’s Coronil tablet, which the company says is an evidence-based drug to fight COVID-19, and demanded an explanation from the Union Minister of Health. Vardhan in whose presence the drug was started.

In a statement released on Monday, the IMA said: “As the country’s health minister, how justified is it in disseminating such a falsely manufactured unscientific product to people across the country … can you? you clarify the schedule, the so-called clinical trial schedule of this said anti-corona product? “

“The country needs an explanation from the Minister. The Indian Medical Association will also write to the National Medical Commission for an explanation suo moto for its blatant disrespect to the Code of Conduct of the Medical Council of India “, said the IMA.

The DMA issued a statement on the IMA statement on Tuesday, saying it “strongly condemns the press release from the Indian Medical Association”.

“The contents of the press release are unfounded, unauthorized, illegal and defamatory to the clean and honest image of the Union Minister of Health, Dr Harsh Vardhan,” he said.

The minister participated in the inaugural program “in his capacity as trade union minister of health and not as a modern doctor,” he added.


Questions raised by the IMA regarding the nature of the CORONIL trial or the WHO’s false certification claims should be answered by the Patanjali Research Institute, the DMA said.

In a statement, Patanjali earlier said: “Coronil has received the Certificate of Pharmaceutical Product (CoPP) from Ayush Section of the Central Pharmaceutical Standards Supervisory Organization in accordance with the WHO certification program.”

However, the WHO for Southeast Asia later said in a tweet: “@WHO has not reviewed or certified the effectiveness of any traditional drug for the treatment of # COVID19.”

Patanjali had introduced Ayurveda-based Coronil on June 23 of last year, when the pandemic was at its peak. It faced severe criticism as it lacked scientific evidence regarding its effectiveness.

(This story was not edited by NDTV staff and is auto-generated from a syndicated feed.)


Note: The content and images used in this article is rewritten and sourced from

Most Popular